The combined effect of the expression levels of MMP-1 and other MMPs, such as MMP-2 and MMP-3, or the MMP expression and genetic variants, on the risk of RA or OA, should be investigated based on the available case-control studies in the future. This evidence concerns the gene MMP3 and rheumatoid arthritis.